Correlation Between 4D Molecular and Homology Medicines
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and Homology Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and Homology Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and Homology Medicines, you can compare the effects of market volatilities on 4D Molecular and Homology Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of Homology Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and Homology Medicines.
Diversification Opportunities for 4D Molecular and Homology Medicines
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between FDMT and Homology is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and Homology Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Homology Medicines and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with Homology Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Homology Medicines has no effect on the direction of 4D Molecular i.e., 4D Molecular and Homology Medicines go up and down completely randomly.
Pair Corralation between 4D Molecular and Homology Medicines
If you would invest 109.00 in Homology Medicines on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Homology Medicines or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 4.76% |
| Values | Daily Returns |
4D Molecular Therapeutics vs. Homology Medicines
Performance |
| Timeline |
| 4D Molecular Therapeutics |
| Homology Medicines |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
4D Molecular and Homology Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 4D Molecular and Homology Medicines
The main advantage of trading using opposite 4D Molecular and Homology Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, Homology Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Homology Medicines will offset losses from the drop in Homology Medicines' long position.| 4D Molecular vs. Eliem Therapeutics | 4D Molecular vs. HCW Biologics | 4D Molecular vs. Scpharmaceuticals | 4D Molecular vs. Milestone Pharmaceuticals |
| Homology Medicines vs. Passage Bio | Homology Medicines vs. Stoke Therapeutics | Homology Medicines vs. Adaptimmune Therapeutics Plc | Homology Medicines vs. Black Diamond Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |